Identity graph
Küleon Bioscience headquarters, locations and relationships
- Industry
- Healthcare
- Founded
- 2021
- Website
- kuleonbio.com
Küleon Bioscience office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Seattle | Washington | United States | Headquarters |
- Parent company
- No parent company recorded in GraphIQ.ai.
Verified from public filings, company websites and news · Methodology
Open in GraphIQ.aiMore Küleon Bioscience data in GraphIQ.ai
This page shows the public record. Sign in with a work email to open the rest of the entity.
-
Technographics (available after sign-in)
Software, cloud and infrastructure in use.
-
Firmographics (available after sign-in)
Revenue, headcount, growth and industry codes.
-
Capabilities (available after sign-in)
Products, services and certifications.
-
News (available after sign-in)
Recent coverage and signals, resolved to the entity.
-
And more (available after sign-in)
Subsidiaries, people and lookalike companies.
Who uses the Küleon Bioscience entity
-
Revenue and GTM teams
Territories, enrichment and account expansion on one resolved account.
RevOps Sales & marketing -
Industry and supply chain
Suppliers, sites and partners mapped to the right legal entity.
Industry -
Private equity and investors
Corporate family, comparable companies and deal sourcing.
Private equity -
Government and public sector
Supplier vetting, ownership and jurisdiction checks against one verified entity.
Government -
Developers and AI agents
The entity and its relationships through the REST API and MCP server.
Developers
About Küleon Bioscience
Küleon Bioscience is headquartered in Seattle, Washington, United States. Founded in 2021, the company employs approximately 6 people worldwide.
Where is Küleon Bioscience's main office?
Küleon Bioscience's main headquarters office is located at Seattle, Washington 98103, United States. This is the company's primary corporate address.
What does Küleon Bioscience do?
Küleon is a drug discovery company focused on developing novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases and disorders. We’ve created a proprietary portfolio of serotonin receptor ligands designed to target neurocircuit abnormalities in the brain that are responsible for difficult-to-treat disorders such as schizophrenia and depression. We have successfully identified several preclinical leads that have significantly improved agonism characteristics such as low-to-no hallucinogenic or cardiotoxic liability, as well as modified PK/PD profiles when compared to other known atypical antipsychotics and serotonergic drugs. Serotonergic drugs have the potential to address multiple indications affecting large population groups that make up extremely sizable markets. This is because many of the current SSRIs and non-selective serotonin receptor agonists were not designed with an eye towards functional selectivity. Our novel compounds are designed for functional selectivity via biased signalling mechanisms, potentially enhancing their therapeutic effect and reducing unwanted side effects. Our proprietary molecular scaffolds and compounds are novel and patentable, providing us with a tremendous strategic foothold in the market as companies continue to explore novel mechanisms of action for targeting neuropsychiatric diseases and disorders. We are collaborating with some of the world’s leading academic researchers and key opinion leaders in the serotonergic and atypical antipsychotic drug development space. Please reach out if you would like learn more about the work we are doing with our collaborators!
One entity, every stage
Put Küleon Bioscience to work across your revenue bowtie
- Target Define the market Build the account list from companies shaped like your best customers, Küleon Bioscience included. Fingerprint search
- Cover Plan territories Küleon Bioscience resolves to one account, so it lands in one territory, once. Territory planning
- Engage Act on timing Leadership changes, funding and M&A arrive linked to the account, not a loose headline. Signal monitoring
- Convert Close on a resolved record Inbound and closed-won attach to one CRM record, with no duplicates to merge. CRM enrichment
- Retain Ground every answer Customer teams and AI agents answer from the same entity, with a source and a date. AI agent data layer
- Expand Find the next buyer inside Follow subsidiaries and divisions to the next team that can buy. Account expansion
About the source
What is GraphIQ.ai?
A B2B identity graph. It resolves each organization into one verified entity and maps its parent and subsidiaries, employees, competitors and news signals. Revenue teams use it in the product; AI agents query it through the REST API and MCP server.
POST/api/v2/organizations/search
Küleon Bioscience: frequently asked questions
Where is Küleon Bioscience headquarters?
Seattle, Washington 98103, United States.
When was Küleon Bioscience founded?
2021.
How many employees does Küleon Bioscience have?
About 6, as of October 2026 (GraphIQ.ai estimate).
Questions about GraphIQ.ai
Is GraphIQ.ai a list of companies like a spreadsheet?
No. Each organization resolves to one verified entity linked to its parent, subsidiaries, people and signals, so Küleon Bioscience here is the same Küleon Bioscience in your CRM, territory plan and agent answers.
Where does this Küleon Bioscience data come from?
Public filings, company websites and news, resolved to one entity and continuously updated.